Judge Slams J&J Spin On Study Suggesting Acetaminophen-Induced Liver Damage
Executive Summary
Johnson & Johnson should address perceived flaws in evidence supporting liver damage by acetaminophen in cross-examination instead of trying to exclude the evidence, says the federal judge overseeing a suit alleging liver damage from use of Tylenol Extra Strength.
You may also be interested in...
J&J Argument Against Liver Damage Experts 'Borders On Ridiculous' – Judge
J&J fails in request to exclude two experts for the plaintiff in bellwether litigation alleging liver damage from indicated doses of Tylenol Extra Strength. The decision represents the second blow in less than a month in J&J's efforts to exclude plaintiff's evidence from the trial.
J&J Argument Against Liver Damage Experts 'Borders On Ridiculous' – Judge
J&J fails in request to exclude two experts for the plaintiff in bellwether litigation alleging liver damage from indicated doses of Tylenol Extra Strength. The decision represents the second blow in less than a month in J&J's efforts to exclude plaintiff's evidence from the trial.
Judge Rejects Prior Restraint For Tylenol Ads Ahead Of 'Bellwether' Trial
J&J/McNeil may continue to advertise the Tylenol line ahead of the first case in multi-district litigation claiming use of the products as labeled is linked to liver damage, says a federal judge. The plaintiff asked the court to prohibit the firm from advertising that could taint the juror pool ahead of the fall trial.